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Abstract
Various aspects of spaceflight, including microgravity, cosmic radiation, and
physiological stress, may perturb immune function. We sought to understand the
impact of microgravity alone on the cellular mechanisms critical to immunity. We
utilized clinostatic RWV bioreactors that simulate aspects of microgravity to analyze the
response of human PBMC to polyclonal activation. PHA responsiveness in the RWV
was almost completely diminished. IL-2 and IFN-7 secretion was reduced whereas IL-
113and IL-6 secretion was increased, suggesting that monocytes may not be as
adversely affected by simulated microgravity as T cells. Activation marker expression
(CD25, CD69, CD71) was significantly reduced in RWV cultures. Furthermore, addition
of exogenous IL-2 to these cultures did not restore proliferation. Reduced cell-cell and
cell-substratum interactions may play a role in the loss of PHA responsiveness.
However, PHA activation in Teflon culture bags that limit cell-substratum interactions
did not suppress PHA activation. Furthermore, increasing cell density and, therefore,
cell-cell interactions in the RWV cultures did not help restore PHA activation. However,
placing PBMC within small collagen beads did partially restore PHA responsiveness.
Activation of both PBMC and purified T cells with PMA and ionomycin was unaffected
by RWV culture, indicating that signaling mechanisms downstream of PKC activation
and calcium flux are not sensitive to simulated microgravity. Furthermore, sub-
mitogenic doses of PMA alone but not ionomycin alone restored PHA responsiveness
of PBMC in RWV culture. Thus, our data indicate that during polyclonal activation the
signaling pathways upstream of PKC activation are sensitive to simulated microgravity.
/Introduction
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Several physiological systems are altered by the environment of spaceflight (1).
Studies over the past two decades show spaceflight to alter immune performance (2).
Psychological and physical stress, cosmic radiation, as well as microgravity are all
potentially responsible for the adverse effects of spaceflight (3). Any of these
perturbations may affect immune performance directly or indirectly. Interpretation of
spaceflight studies is confounded by the inability to isolate the direct effect of
microgravity on cells from the other factors associated with spaceflight. Since immune
performance is complex and reflects the influence of multiple organ systems within the
host, we sought to understand the potential impact of microgravity alone on the cellular
mechanisms critical to immunity. We achieved this by isolating immune cells ex vivo
and challenging them with simulated microgravity within an experimental setting.
We utilized Rotating Wall Vessel (RWV) 3 bioreactors developed at NASA's
Johnson Space Center that simulate aspects of microgravity (4, 5). The RWV
bioreactors are based on a previous clinostat design (6). The RWV consists of a zero
head-space cylindrical culture vessel that rotates at a slow speed around a horizontal
axis. These conditions create a solid fluid body that can suspend cells or small
particles in a perpetual free fall condition simulating conditions of microgravity for cell
cultures (7). The system provides us with the ability to assess immune function at a
cellular level, without the confounding influences of psychoneuroendocrine factors.
Cells can also be analyzed while they are experiencing simulated microgravity rather
than after they have been exposed. The RWV was used to demonstrate suppression of
lymphocyte locomotion through collagen by simulated microgravity that correlated with
similar orbital flight studies (8)._ The RWV bioreactor provides for a unique opportunity
to study the response of cells to microgravity without the limitations of flight
experiments.
Many orbital experiments have analyzed the immune system's response to
microgravity and spaceflight. Astronauts post-flight of long-duration missions have an
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increase in leukocyte count, a decrease in T cell count, decreased mitogen induced IL-
2 production, and decreased response to PHA (9). Astronauts post-flight of short-
duration missions have a decrease in lymphocyte count, an increase in neutrophil
count, and a decreased response to PHA (10). Astronauts in-flight of both long. and
short-duration missions have a reduced delayed-type hypersensitivity skin test
response (9-11). Furthermore, in vitro experiments performed in both true and
simulated microgravity demonstrate a suppressed response of lymphocytes to mitogens
(12-17).
In our current study, we used the RWV to further characterize the suppression of
PHA responsiveness by simulated microgravity. Cytokine secretion was measured to
determine the activity of lymphocytes and accessory monocytes in this system. We
found monocyte associated cytokines, IL-113 and IL-6, to be elevated while T cell
associated cytokines, IL-2 and IFN-T, were reduced. Activation marker expression was
also reduced in RWV cultures. Early markers, CD69 and CD25, were slightly
upregulated in RWV cultures but the late marker CD71 was not induced. Several
experiments were designed to address the possible reduced cell-cell and cell-
substratum interactions that microgravity could impart. Lymphocytes were activated
with PHA in Teflon culture bags to assess the role of the limitation of cell-substratum
interactions on activation. Proliferation was unchanged in the Teflon culture bags. Cell
densities in the RWV's were increased to enhance cell-cell interactions and facilitate
activation. We found that increasing cell densities to high levels did not aid activation in
simulated microgravity. However, partial restoration of PHA responsiveness in the
RWV was achieved by placing PBMC within small collagen beads prior to activation in
the RWV. Several experiments addressed the status of signaling messengers in PHA
activated lymphocytes in the RWV. Both PBMC and column purified T cells could be
activated with PMA and ionomycin in the RWV. Furthermore, sub-mitogenic doses of
PMA could restore PHA activation in the RWV. Ionomycin alone had no effect on PHA
activation. These experiments suggest that the calcium signaling pathway may be
6intact during PHA stimulation in the RWV and that signal transduction mechanisms
upstream of protein kinase C (PKC) activation are sensitive to simulated microgravity.
IMaterial and Methods
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Cells and Media
Normal human blood buffy coats were obtained from the Gulf Coast Regional Blood
Center (Houston, TX). The PBMC were isolated from the buffy coats on a Ficoll-
Hypaque gradient (Pharmacia LKB, Piscataway, PA), washed three times in HBSS, and
resuspended in complete RPMI 1640 (GibcoBRL, Grand Island, NY) supplemented with
10% heat-inactivated FBS (Hyclone Labs, Logan, UT) and penicillin(100 U/ml)-
streptomycin(100 IJg/ml, GibcoBRL). Purified T cells were isolated from PBMC's
cleared of erythrocytes (Erythrocyte Lysing Kit, R&D Systems, Minneapolis, MN) on T
cell enrichment columns (R&D Systems).
RWV bioreactor
The RWV bioreactor (Synthecon, Houston, TX) is a cylindrical culture vessel with zero
headspace and a silicon membrane for direct gas exchange with the culture medium.
For each experiment, a sterile 55 ml RWV was filled completely with complete medium
and bubbles were removed through the syringe ports. The vessel was conditioned for
at least one hour by rotating the vessel at 14 rpm in a humidified 37°C incubator with
approximately 1 L/min 5% CO2, 95% air pumped passed the oxygenation membrane.
After the conditioning period, cells and reagents were introduced to the RWV through
the syringe ports or the main port. The vessel was then incubated as described above.
The vessels must remain completely filled throughout the experiment. Therefore, cells
and media that were sampled were replaced by fresh media. Typically, 5 ml samples
were taken by pumping 5 ml of fresh media into one syringe port while simultaneously
withdrawing 5 ml from the other syringe port. Cells were then set up in proliferation
assays and supernatant was frozen at -20°C for later analysis. Due to the limited
number of available RWV bioreactors and the limited number of total cells obtainable
8from a single donor buffy coat, most experiments were repeated independently at least
three times. The data shown are of one representative experiment.
PHA stimulation and proliferation assays
PBMC (1 x 106 cells/ml) were stimulated with 5 IJg/ml phytohemagglutinin (PHA-M,
Sigma, St. Louis, MO) in standard T-75 tissue culture flasks, 55 ml RWV's, or 100 ml
Teflon culture bags (American Fluoroseal Corp., Columbia, MD). For the IL-2 study,
recombinant human IL-2 (GibcoBRL)was also added at 10, 50, and 100 U/ml. For the
PMA/ionomycin study, PMA (0.5 - 5 ng/ml) and ionomycin (50 - 500 ng/ml, both from
Sigma) were added to the PHA cultures. Rotation of the RWV was started immediately
except for the static pre-incubation period studies where several RVVV's were held
stationary for 30 - 180 min and thereafter rotated. RWV's and T-flasks were incubated
as described above. Proliferation was determined for sampled cells by [3H]thymidine
incorporation. Sampled PBMC (2 x 105 cells/well) were labeled with [methyl-
3H]thymidine (1 IJCi/well, 5 Ci/mmol, Amersham Life Sciences, Arlington Heights, IL) in
triplicate for 18 hours in standard 96 well plates, harvested onto glass filter paper, and
analyzed by standard liquid scintillation techniques. The data are presented as A cpm
(experimental cpm minus background cpm).
Cytokine measurement
PBMC (2 x 106 cells/ml) were stimulated with 5 pg/ml PHA in both a 55 ml RWV and a
T-75 T-flask. At the time points shown, culture media samples were collected, cleared
of cells and particles by centrifugation, and frozen at -20°C for later analysis. Later, the
supernatants were thawed, diluted as needed, and run on BioSource Cytoscreen
ELISA kits for IL-113, IL-2, IL-6, and IFN-_, (Camarillo, CA) as described in their
protocols. The media was diluted 2, 10, and 20-fold to keep results within the range of
standard curves. The plates were read on a Dynatech MRS plate reader and analyzed
with Dynatech BioLinx software (Chantilly, VA).
9Flow cytometry
mAbs: CD25-Spectral Red (Tu69, Southern Biotechnology Associates, Birmingham,
AL), CD69-R-Phycoerythrin (Leu23, Becton-Dickerson, San Jose, CA), and CD71-FITC
(BerT9, Dako, Carpinteria, CA). Sampled PBMC (1 x 106 cells/reaction)were stained
with 10 pl of each labeled antibody in 100 pl PBS with 2% FBS (staining buffer) for 30
minutes on ice and in the dark. The cells were washed twice in staining buffer and then
resuspended in 500 pl 1% paraformaldehyde. Antibody binding was analyzed on a
Coulter flow cytometer.
Collagen bead assay
PBMC were incorporated into small collagen beads. Collagen solutions were prepared
as described previously (18, 19). Briefly, a stock type I collagen solution (2 mg/ml) was
prepared from frozen rat tail tendons (PeI-Freeze, Rogers, AK). A concentrated
complete medium solution was prepared by combining 20 m110X RPMI-1640
(GiboBRL), 20 ml FBS (Hyclone), 10 ml 7.5% NaHCO3 (GiboBRL), and 2 ml 100X
penicillin/streptomycin (GiboBRL). To create a collagen polymerization solution, 6 ml of
stock collagen solution was combined with 1 ml concentrated complete medium
solution, 300 pl 7.5% NaHCO3, and 250 pl 0.34N NaOH on ice. PBMC (3 x 10 z
cells/ml) were suspended in the collagen polymerization solution on ice. Beads were
produced by pipetting 25 pl of cell-collagen solution into sterile wells of Terasaki
microtiter plates (Nunc, Intermountain Scientific, Bountiful, UT) yielding 7.5 x 105
cells/bead. The beads were then polymerized by incubating the plates at 37°C for 2-3
minutes. The beads were removed from the plates and put into either a 55 ml RWV or
T-75 T-flask containing complete RPMI with 5 pg/ml PHA at a concentration of
approximately 100 beads per vessel. The RWV and T-flask were incubated as
described above.
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At the time points shown, beads were sampled from the vessels, collected and
washed briefly with HBSS on Falcon nylon cell strainers (Fisher, Houston, TX). The
collagen beads were then digested with a collagenase cocktail containing 0.7 mg/ml
collagenase type III, 0.5 mg/ml collagenase type IV, 0.1 mg/ml DNAse (all from
Worthington, Freehold, NJ), 25 mM HEPES, 5% FBS, in PBS for 30 min in a 37°C
shaking water bath. The cells were collected by centrifugation and washed 2 times in
complete RPMI. The collected PBMC were set up in a proliferation assay as described
above.
PMA and ionomycin activation assay
PBMC or column purified T cells (2 x 10s cells/ml) were stimulated with PMA (5 ng/ml)
and ionomycin (500 ng/ml) for 4 hours in both a RWV and T-75 T-flask. To minimize
the toxic effects of PMA and ionomycin, the cells were isolated by centrifugation after 4
hours and reconstituted in fresh media without PMA and ionomycin. The cells were
then cultured in a new RWV or T-flask for three days. After three days, sampled cells
were set up in a proliferation assay as described above.
Results
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Proliferation in the RWV bioreactor
Several immunological functions have been assessed in astronauts during and post
spaceflight. The response of PBMC to polyclonal activation by PHA is a basic
lymphocytic function. PHA stimulates T cells by crosslinking the TCR/CD3 complex as
well as other cell membrane glycoproteins (20-22). There is a requirement for
monocytes in the culture to provide costimulation through both physical contact and
soluble factors (23). The response to PHA of lymphocytes from astronauts is
suppressed after spaceflight (9, 10). Furthermore, the PHA responsiveness of
lymphocytes cultured in clinostatic rotation and true microgravity is suppressed (12-17).
The RWV bioreactors are an adaptation of clinostatic technology and therefore, we
were interested in analyzing the response of PBMC to PHA in our system. PBMC were
cultured for three days with PHA in the RWV bioreactors. We found proliferation to be
almost completely suppressed in the RWV bioreactor at all time points measured (Fig.
1). Lymphocytes in the RWV cultures do aggregate and remain viable but do not form
blasts. We concluded that the RWV bioreactor is an appropriate system for studying
the suppressi(:;n of lymphocyte activation by simulated microgravity.
Cytokine secretion in the RWV bioreactor
Within a PBMC population, cytokines secreted from both T cells and accessory
monocytes are important for the proliferative response of T cells to PHA. IL-2 is a key
autocrine cytokine in the activation and differentiation process of T cells. IL-I_ and IL-6
are important costimulatory cytokines secreted by monocytes (24-28). The activity of
lymphocytes and monocytes within the PBMC population stimulated with PHA in the
RWV bioreactor was analyzed by their cytokine secretion profiles. We analyzed the
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supernatants from cultures of PBMC activated with PHA in the RWV bioreactor for the
presence of IL-2, IFN-T, IL-113 and IL-6 (Fig. 2). The secretion of T cell associated
cytokines, IL-2 and IFN-y, was suppressed in the RWV bioreactor. IL-2 was
undetectable throughout the experiment. Interestingly, IFN-T secretion was initially
suppressed but returned to normal levels at day three. Rather than being suppressed,
the secretion of costimulatory cytokines, IL-113 and IL-6, was dramatically enhanced in
the RWV bioreactor. The secretion profiles of these cultures demonstrate that
monocytes and lymphocytes may respond differently to simulated microgravity. Thus,
RWV culture suppressed lymphokine secretion whereas it enhanced monokine
secretion.
Activation marker expression in the RWV bioreactor
PHA stimulation induces the expression of numerous cell surface molecules some of
whose expression is required for complete activation (29). To gauge the extent of
activation of our RWV cultures we analyzed the expression of three activation markers:
CD25 (inducible o_-chain of the IL-2 receptor) (30), CD69 (EA-1, Leu23, AIM) (31, 32),
and CD71 (transferrin receptor) (33). PBMC from PHA cultures were analyzed by flow
cytometry for both percentage stained cells and mean fluorescence intensity (MFI).
While the late marker, CD71, failed to be induced in the RWV cultures, the induction of
the early markers, CD25 and CD69, was suppressed by over 50% (Fig. 3A).
Furthermore, of those cells that were positive for CD25 and CD69 in the RWV
bioreactor, the MFI was significantly reduced (Fig. 3B). Thus, some early activation
marker expression was seen in the RWV cultures but the number of positive cells and
the MFI of those cells were significantly reduced.
Addition of exogenous IL-2 to PHA-RWV cultures
13
IL-2 is a key growth factor for T cells during activation. The interaction of IL-2 with its
high affinity receptor on the T cell represents a committed step toward proliferation (34).
Since IL-2 levels were undetectable in the PHA-RWV cultures, we added exogenous
recombinant IL-2 to our PHA-RWV cultures to attempt to reconstitute proliferation.
Various concentrations of recombinant IL-2 were added along with PHA to PBMC
cultures in the RWV bioreactor. No amount of IL-2, even as high as 100 U/ml, could
significantly restore lymphocyte proliferation to the control values (Fig. 4). Interestingly,
the RWV culture actually suppressed some of the background proliferation caused by
IL-2 alone.
Role of cell-cell and cell-substratum interactions on activation in the RWV bioreactor
It is important to consider characteristics of microgravity and rotational culture other
than those directly related to gravitational effects. Cultures may be affected by the lack
of sedimentation that occurs in space as well as in clinostatic bioreactors. There is a
potential for cell-cell and cell-substratum interactions to be reduced under these
conditions. We designed three experiments to address these concerns. PBMC were
stimulated with PHA in Teflon culture bags to mimic the potential reduced cell-
substratum interactions of the RWV bioreactor. These Teflon culture bags greatly
impair the ability of cells to bind to and interact with the bag surface and are primarily
used to force monocytes to grow in suspension (35). PBMC activated with PHA in
Teflon culture bags proliferated to the same levels as those activated in standard T-
flasks (Fig. 1). The reduced cell-substratum interactions of these conditions did not
effect the ability of the cells to respond to PHA. Therefore, reduced cell-substratum
interactions in the RWV bioreactor may not be important to the suppression of PHA
activation.
Reduced cell-cell interactions may play a role in the suppressed response of
PBMC to PHA in simulated microgravity. PBMC were stimulated with PHA in the RWV
14
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bioreactor at higher than usual cell densities to augment cell-cell interactions. Two
separate donor buffy coats had to be used for each higher cell density due to the limited
total cell number obtainable from a single buffy coat unit and the volume demands of
the RWV bioreactor. Increasing the cell density to 5 xl06 and 1 x 107 cells/ml did not
help restore the proliferation of the PBMC (Fig. 5A, 5B). Therefore, the possible
reduced cell-cell interactions in the RWV bioreactor may not be important to the
suppression of PHA activation.
However, to further augment cell-cell and cell-substratum interactions in the
RWV bioreactor, PBMC were polymerized within small collagen beads at a high cell
population density. Within the beads the cells could interact with each other and the
collagen matrix. The beads were suspended in the RWV bioreactor and stimulated with
PHA. Later, cells were isolated from the collagen and analyzed. The proliferation of
PBMC within collagen beads stimulated with PHA in the RWV bioreactor was restored
by approximately 50% (Fig. 6). Thus, providing a stable support for the cells helped
them resist the adverse effects of simulated microgravity.
Effect of non-rotated pre-incubation period on activation in the RWV bioreactor
Simulated microgravity could interfere with the T cell activation process at several
points. We were interested in localizing points along the T cell activation signal
transduction pathway that were sensitive to microgravity. Therefore, we provided PHA
cultures with "head-starts" by allowing them to pre-incubate in the presence of normal
gravity before they were exposed to simulated microgravity in the RWV bioreactors.
PBMC were allowed to pre-incubate with PHA in non-rotating (non-microgravity
simulating) RWV bioreactors for several periods of time. After the pre-incubation
period, the RWV bioreactor's rotation was started (microgravity simulating) at the
normal speed and continued rotating for three days until cells were sampled for
analysis. One RWV bioreactor remained stationary for the entire experiment (72 hr).
The longer the RWV cultures were allowed to pre-incubate at normal gravity the more
15
J
proliferation was restored (Fig. 7). Some proliferation was restored after as short as 30
minutes at normal gravity. This suggests that once cells are allowed to start their
activation process in normal gravity, they can continue on to proliferation even in
simulated microgravity. Furthermore, the cells that remained in the non-rotated RWV
bioreactor for the entire experiment (72 hr) proliferated to the control levels. This
demonstrates that the suppression of proliferation seen in the RWV bioreactors is due
to the rotation (microgravity simulation) and not other conditions of the vessels.
PMA and ionomycin activation in the RWV bioreactor
Two of the main activation signals of PHA activation are sent through the PKC and the
calcium secondary messenger systems (36). To locate signaling mechanisms of the T
cell activation process that are sensitive to simulated microgravity, we activated PBMC
and column purified T cells with PMA and ionomycin. The direct activation of PKC by
PMA and the addition of a calcium ionophore sufficiently drives T cells to proliferate
without the need for monocyte costimulation or crosslinking of molecules on the cell
surface. Proliferation of PMA/ionomycin activated PBMC and column purified T cells
was not significantly affected by RWV culture (Fig. 8A, 8B). We therefore conclude that
activation mechanisms downstream of PKC activation and calcium flux are not sensitive
to simulated microgravity. Once cells are advanced to this stage of the T cell activation
process, they are resistant to the suppressive effects of simulated microgravity. This
may account for the proliferation seen in cells allowed to pre-incubate in normal gravity
(Fig. 7).
Both the PKC and calcium signals are required for PHA to drive T cells to
proliferate. One or both of these signals may be defective in the activation of T cells in
the RWV bioreactor. To address this we added PMA and ionomycin, alone and
together, to PHA cultures of PBMC in the RWV bioreactors. If either of the two signals
are defective, the PMA or ionomycin should be able to complement the system and
allow proliferation. Sub-mitogenic concentrations of PMA alone, but not ionomycin
alone, was able to restore some proliferation in the PHA-RWV cultures. PMA and
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ionomycin together also restored proliferation but no more than PMA alone. These
concentrations of PMA and ionomycin were shown to be sub-mitogenic since a culture
of both in a T-flask without PHA produced no proliferation (Fig. 9A). Several mitogenic
concentrations of PMA were effective at restoring proliferation in the PHA-RWV cultures
(Fig. 9B). No concentration of ionomycin from 50 ng/ml to 500 ng/ml significantly
restored proliferation in the PHA-RWV cultures (Fig. 9C). These results suggest that
the calcium signal is functioning in the PHA-RWV cultures but the PKC signal is not.
Therefore, the signaling pathways upstream of PKC activation are sensitive to
simulated microgravity.
Discussion
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All the biological systems on our planet have evolved in a gravity environment with a
constant accelerational force of 9.8 m/s 2. How cellular systems will respond to the loss
of this physical force is poorly understood. We focused on the immune system and
specifically the activation and proliferation of lymphocytes which is critical to immunity.
The suppression of the lymphocytic PHA response has been observed in both the
lymphocytes of astronauts after spaceflight and in in vitro experiments in true and
simulated microgravity (9, 10, 12-17). Using the RWV bioreactors in our lab to simulate
microgravity, the direct effects of gravity changes on isolated lymphoid cell populations
were demonstrated by the dramatic reduction of PHA responsiveness (Fig. 1). The
present study focused on the mechanism of this suppression. We have isolated the
location of the impairment in the T cell activation process to pathways upstream of PKC
activation.
The stimulation of T cells to proliferate by PHA is a complex process involving
both T cells and accessory cells (monocytes and B cells in a PBMC population). PHA,
a lectin, binds to and crosslinks cell surface glycoproteins. Specifically on T cells, PHA
can crosslink CD2, CD3, and the TCR complex, as well as other glycoproteins, and
provide for receptor capping to initiate a sufficient activation signal into the cell (20-22).
Costimulation is required and is provided by accessory monocytes through soluble
factors such as IL-11], IL-6, and TNF-_, as well as possibly by cell-cell ligand interaction
(24-28). We found the cultures activated with PHA in simulated microgravity to have
sufficient costimulation in the form of IL-113 and IL-6 (Fig. 2). In fact, the levels of these
cytokines were increased. Increased secretion of these cytokines has been seen
previously in cells exposed to microgravity in orbit (37, 38) and may reflect a cellular
response to stress. The increased levels of IL-I_ and IL-6 in the PHA-RWV cultures
could also indicate reduced uptake of these cytokines by receptors on the T cells. The
expression of cytokine receptors can significantly remove cytokines from the cultures
through receptor binding and internalization. This can be seen as early as two days for
18
IL-2 in the T-flask cultures (Fig. 2). Therefore, the increased IL-113 and IL-6 levels may
indicate a reduced IL-113 receptor and IL-6 receptor expression. This may explain the
failure of the T cells to respond to the costimulatory cytokines. The key response to
costimulation, the expression of the T cell autocrine growth factor IL-2, was completely
absent in the PHA-RWV cultures. Previous flight studies by Cogoli et al. have
measured both reduced (15) and normal (12) levels of IL-1 in cultures activated with
Con A in microgravity. Our results support the latest findings that IL-1 secretion is not
adversely affected in microgravity. IL-1 is a strong costimulatory signal for T cells and
can provide the second signal required to initiate IL-2 production (26). In the PHA-RWV
cultures, the IL-I_ signal was strong but the T cells failed to initiate IL-2 production.
This suggests there may be a lack of appropriate cytokine receptor expression or that
there is a block in the costimulation signal transduction mechanism. Furthermore, the
induction, production, and secretion of cytokines reflect a complex interplay of cytokine
networks. The interference of these networks may result in unusual, and not easily
explained, results such as the delayed secretion of IFN-y, a key T cell effector cytokine.
The expression of activation markers indicates that while the T cells were not
completely unresponsive to the PHA signal, their activation state was weak at best.
CD25 and CD69, two early markers, were upregulated on about 40% of the cells (Fig
3A). However, the MFI was very low compared to control levels (Fig. 3B). These
results suggest that the PHA signal was not completely shut down at the surface of the
T cell but rather the signal was not sufficient for full activation. The T cells did not
advance to the later stage of activation as indicated by the lack of CD71 expression.
While the monocytes were active, the T cells failed to respond to the costimulation, to
produce IL-2, and to commit to proliferate. Furthermore, the failure to proliferate was
not simply due to the lack of IL-2 since exogenous IL-2 could not restore proliferation
(Fig. 4). This was not surprising considering the low amount of high affinity IL-2
receptor on the cell surface. Similar flight studies have also failed to restore mitogen
activated proliferation with both exogenous IL-1 and IL-2 (12). These results suggest
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that both reduced cytokine and cytokine receptor expression may be critical to the
suppression of T cell activation in microgravity.
Although some studies suggest there may be a microgravity induced PKC defect
(39, 40), we were able to fully activate T cells to proliferate in simulated microgravity
with PMA and ionomycin (Fig. 8A, B). The pharmacological agents PMA, a phorbol
ester, and ionomycin, a calcium ionophore, act synergistically to activate T cells to
proliferate. These agents bypass the mechanisms at the cell surface and impart their
effect inside the cell: PMA by mimicking 1,2-diacylglycerol (DG) and activating the
serine/threonine kinase PKC; ionomycin by increasing the cytoplasmic free calcium ion
concentrations (36). The ability to activate T cells in the RWV with PMA and ionomycin
implies that all the cellular mechanisms involved in T cell activation downstream of PKC
activation and calcium ion flux are intact in simulated microgravity. These results
provide insight on why PHA responsiveness could be partially restored by pre-
incubating PHA cultures at normal gravity before exposing them to simulated
microgravity (Fig. 7). Cells that achieved PKC activation and calcium flux could
continue on to proliferate even when they were exposed to simulated microgravity.
Since PKC activation and calcium flux occur quickly after receptor triggering, one might
expect full activation to be restored by pre-incubating the PHA cultures. Although these
events do occur within minutes, sustained receptor triggering of up to 48 hours is
required for optimal lectin activation (41). Once the pre-incubated cultures were
exposed to simulated microgravity the signal from the receptor was no longer sustained
due to the microgravity induced lesion somewhere upstream of PKC activation.
The signaling pathways upstream of PKC and not upstream of calcium are
sensitive to simulated microgravity. This conclusion is based on the observation that
PMA alone could restore PHA responsiveness, while ionomycin alone could not (Fig.
9A, B, C). Since the direct activation of PKC alone could restore PHA responsiveness,
the calcium pathway is probably intact in the PHA-RWV cultures. The main activating
molecules of PKC and calcium flux, DG and inositol trisphosphate (IP3), respectively,
come from the cleavage of the same precursor, phosphatidylinositol 4,5-bisphosphate
(PIP2)(42). Therefore, if calcium flux is intact, the cleavage of PIP2 is likely intact and
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some signaling from the TCR/CD3 complex is present. We speculate that the
interaction of DG with PKC is aberrant in simulated microgravity. However, the levels of
intracellular calcium, IP3,and DG have not been determined for PHA cultures in
simulated microgravity. Secondly, the data suggest that the T cells are not receiving or
processing the costimulation signal. PKC function is critical to costimulatory signals
being transferred from the cell membrane to the nucleus. Activation of PKC with
phorbol esters can mimic costimulation (43, 44). Therefore, the addition of PMA to the
PHA-RWV cultures could possibly fulfill the lacking costimulation signal needed to
upregulated IL-2 and initiate proliferation.
It is important to consider indirect effects that simulated microgravity has on cell
culture conditions and what role they play in the suppression of T cell activation. Since
cells remain dispersed throughout the media in the RWV, the interactions of cells with
both substratum and other cells may be altered. There is evidence that PHA activation
of PBMC requires cell contact between monocytes and T cells (45). Despite cells
remaining dispersed in RWV cultures, there is evidence that normal cell-cell interactions
do take place in cell cultures exposed to true and simulated microgravity. Aggregation
of cells occurs in mitogen activated PBMC in microgravity (16, 46) and was observed in
the PHA-RWV cultures. A suspension of cells will adhere to microcarriers in the RWV
(8, 47). Furthermore, in the current study, IL-113secretion in the PHA-RWV cultures
was present. There is evidence that cell contact between T cells and monocytes
through LFA-1 and CD69 is required for monocytes to produce IL-1 (48, 49).
Nonetheless, cell-cell and cell-substratum interactions may be weaker in the RVVV.
However, when we tried to increase the amount of cell-cell contact by increasing cell
densities in the RWV, proliferation was not restored (Fig 5A, B). Although some studies
suggest that cell-substratum interaction is important to T cell activation (50),we found
that PBMC activated with PHA in Teflon culture bags was unaffected (Fig 1). The
ability of cells to interact with substratum may not be as important as the ability to
interact with other cells. However, when PBMCwere secured inside collagen beads,
some proliferation was restored. Similar resultswere seen in an orbital flight study by
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Cogoli et al. (15, 17). In their study, PBMC adhered to microcarriers and exposed to
microgravity in earth orbit had an increased proliferative response to Con A than those
in suspension or even those on microcarriers at normal gravity. How providing for
adherence helped the PBMC resist the effects of RWV culture is not clear. Some
studies suggest that the cytoskeleton is a gravity receptor for eucaryotic cells (51-53).
This hypothesis proposes that cells exposed to microgravity are altered through
changes in the cytoskeleton. Furthermore, lymphocytes exposed to microgravity
undergo cytoskeleton-independent cell shape changes (54). It is possible that once
cells adhere to collagen through adhesion molecules, which connects to the
cytoskeleton via focal adhesion points, cells might be resistant to cell shape changes
and cytoskeleton alterations caused by microgravity. Again, this is speculative at this
point but certainly the response of the cytoskeleton to microgravity is an important area
of study in relation to suppressed T cell activation. This is especially true considering
the potential importance of both cell shape (55) and cytoskeletal elements (56) to T cell
activation.
The suppression of PHA activation of T cells by simulated microgravity may be
caused by several factors. The activation signals from both the primary TCR/CD3
signal and the costimulatory signals may be blocked at the activation of PKC. Adhering
PBMC to substratum may help cells resist some of the adverse effects of simulated
microgravity by helping them resist cell shape and cytoskeleton alterations. Further
analysis of microgravity induced T cell unresponsiveness should provide insight on the
roles of costimulation, the cytoskeleton, cell shape, cell contact, and cell-substratum
interactions in polyclonal activation of T cells under normal conditions. The RWV
bioreactor is only a simulation of microgravity and results found from these studies
should be repeated in true microgravity. However, orbital flight studies are expensive,
limited, and logistically tedious. Therefore, results from RWV bioreactor experiments
are extremely valuable in directing the design of future flight studies by allowing the
testing of hypotheses on earth.
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FIGURE 1. PHA activation in the RVVVbioreactor and Teflon culture bags. PBMC
were stimulated with 5 IJg/ml PHA for three days in three 55 ml RWV's, three Teflon
culture bags, and three T-75 T-flasks. At each time point, 5 ml of culture was sampled
from the vessels and 2 x 10s cells/well were set up in an 18 hour [3H]thymidineassay in
triplicate. Data are expressed as mean + SEM of triplicate cultures.
FIGURE 2. Cytokine secretion of PHA activated PBMC in the RWV bioreactor. PBMC
were stimulated with 5 pg/ml PHA for three days in a 55 ml RWV and a T-75 T-flask.
At each time point, 5 ml of culture was sampled and the supernatant was frozen for
later analysis. Culture supernatants were analyzed for cytokines by ELISA. The data
are representative of three independent experiments.
FIGURE 3. Activation marker expression of PHA activated PBMC in the RWV
bioreactor. PBMC were stimulated with 5 pg/ml PHA for three days in a 55 ml RWV
and a T-75 T-flask. At each time point, 5 ml of culture was sampled and 1 x 106 cells
were tripled stained for CD25, CD69, and CD71. Results are expressed as percentage
positive cells (A) or mean fluorescence intensity (B). The data are representative of
three independent experiments.
FIGURE 4. The effect of exogenous IL-2 on PHA activation in the RWV bioreactor.
PBMC were stimulated with 5 IJg/ml PHA with and without the presence of IL-2 for three
days in a 55 ml RWV (open bars) and a T-75 T-flask (closed bars). PBMC were also
stimulated with IL-2 alone in a T-75 T-flask (hatched bars). Sampled PBMC from each
vessel were set up in an 18 hour [3H]thymidine assay in triplicate (2 x 105 cells/well).
The data are representative of three independent experiments.
FIGURE 5. Effect of cell density on PHA activation in the RWV bioreactor. PBMC were
stimulated with 5 pg/ml PHA at standard cell densities (1 x 106 cells/ml) and higher cell
densities: A: 5 x 106 cells/ml; B: 1 x 107 cells/ml in a 55 ml RWV and a T-75 T-flask for
three days. At each time point, 5 ml of culture was sampled from the vessels and 2 x
10 Scells/well were set up in an 18 hour [3H]thymidine assay in triplicate. The data are
representative of three independent experiments.
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FIGURE 6. PHA activation within collagen beads in the RWV bioreactor. PBMC were
polymerized within 25 pl of type I collagen. The cells/beads were stimulated with 5
pg/ml PHA in a 55 ml RWV and a T-75 T-flask for three days. At each time point,
beads were sampled from the vessels and digested with a collagenase cocktail.
Isolated PBMC were set up in an 18 hour [3H]thymidine assay in triplicate (2 x 105
cells/well). The data are representative of three independent experiments.
FIGURE 7. Effect of a static (non-rotating) pre-incubation period on PHA activation in
the RWV bioreactor. PBMC were stimulated with 5 pg/ml PHA for three days in 55 ml
RWV's and a T-75 T-flask. Several RWV's were initially allowed to pre-incubated with
cells and PHA in a non-rotating (non-microgravity simulating) condition for several
lengths of time. After each pre-incubation period the RVVV was rotated at its usual
speed except for the 72 hr RWV which remained non-rotated for the entire experiment.
Sampled PBMC from each vessel were set up in an 18 hour [3H]thymidine assay in
triplicate (2 x 105 cells/well). The data are representative of three independent
experiments.
FIGURE 8. PMA/ionomycin activation in the RWV bioreactor. PBMC (A) and column
purified T cells (B) were stimulated with PMA and ionomycin for 4 hours in a 55 ml RWV
and a T-75 T-flask. After 4 hours the cells were placed into fresh PMA and ionomycin
free medium and appropriate vessels (RWV or T-flask) and cultured for three days.
Sampled cells from each vessel was set up in an 18 hour [3H]thymidine assay in
triplicate (2 x 105 cells/well). The data are representative of three independent
experiments.
FIGURE 9. Addition of PMA and ionomycin to PHA activation in the RWV bioreactor.
A, PMA (0.5 ng/ml), ionomycin (50 ng/ml), or both were added to PBMC cultures
stimulated with PHA (5 pg/ml) in a 55 ml RVVV and a T-75 T-flask. B, Several
concentrations of PMA were added to PBMC cultures stimulated with PHA (5 IJg/ml) in
a 55 ml RWV and a T-75 T-flask. C, Several concentrations of ionomycin were added
to PBMC cultures stimulated with PHA (5 pg/ml) in a 55 ml RWV and a T-75 T-flask.
Sampled PBMC from each vessel were set up in an 18 hour [3H]thymidine assay in
triplicate (2 x 105 cells/well). The data are representative of three independent
experiments.
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